Click here to view the July 2023 edition of The Meeting Place!
News
In this short video, Mike Davies, CEO of Carocell Bio, shares insights into their fascinating technology and how it could improve the lives of patients with anti-inflammatory peptides applied topically to the skin. This approach has great potential to treat and prevent the recurrence of eczema and has potential anti-ageing properties.
Scaling up – how space is the key ingredient to superpower status
Domainex significantly expands its footprint, leasing the first of three new laboratory buildings at Unity Campus
Edinburgh and Cambridge, UK, 7 July 2023 - Macomics Ltd, a leader in macrophage drug discovery, is delighted to announce that it was voted as the winner of the 2023 BioNewsRound Award for the news of its worldwide drug discovery collaboration agreement with Ono Pharmaceutical Co., Ltd.
Dr Stevens promoted from Director of Drug Discovery, and Dr Kirby promoted from Director of Operations
Cambridge, UK, 06 July 2023: Metrion Biosciences Limited (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointments of Dr Robert Kirby to Chief Operating Officer and Dr Edward Stevens to Chief Scientific Officer. Both appointments represent promotions from within the company.
Life Sciences industry entrepreneur joins the region’s Life Science & Healthcare membership organisation
Here are four interesting insights from the report:
• Amid inflation, talent shortages and other disruption, savvy biotech’s are focusing on the fundamentals of preserving cash and producing strong data and evidence to showcase their overall resilience to potential investors.
• In light of the recently passed Inflation Reduction Act and its impact on drug pricing, inflationary rebates and Medicare Part D redesign, biotech leaders need to take a strategic approach around commercialization, launch sequencing and other areas.
IPO Quarterly Report
In Q2 2023, emerging markets are thriving amid a slow global IPO market.
In brief
• In the first half of 2023, global IPO volumes fell 5%, with proceeds down 36% YOY.
• The US had its largest offering since November 2021.
• Asia-Pacific continues to dominate with an approximate 60% share of global IPOs.
28 June 2023 - Private equity buyouts in the UK healthcare sector including life sciences increased 14%* in Q1 2023 and remain ahead of pre-pandemic levels, even in the face of economic headwinds. With high levels of capital available to be deployed, its expected private equity interest will continue to be elevated, says RSM UK.